Knight Therapeutics Stock
?
Your prediction
Knight Therapeutics Stock
Pros and Cons of Knight Therapeutics in the next few years
Pros
Cons
Performance of Knight Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 0.820% | 0.826% | 6.087% | 61.376% | 63.978% | 85.976% | 78.363% |
| Biomark Diagnostics Inc. | -0.630% | 1.274% | 0.633% | 85.965% | 15.217% | 122.378% | 123.944% |
| MicroPlanet Technology Corp | -0.770% | 3.175% | 8.333% | -10.959% | -14.474% | -23.077% | -26.966% |
| Avricore Health Inc. | 26.000% | -9.524% | 14.000% | -35.955% | 23.913% | -72.596% | -70.000% |
News
Why Shares in Knight-Swift Transportation Crashed This Week
Knight-Swift Transportation (NYSE: KNX) is the largest full truckload carrier in the U.S., and it's always going to be at the center of the never-ending debate over where trucking companies are in
Integra LifeSciences Says Transformation Is Working as SurgiMend Relaunch Nears
Integra LifeSciences (NASDAQ:IART) is keeping its core strategy intact following a leadership change that returned Stuart to the roles of chairman and chief
Rapid Micro Biosystems Q1 Earnings Call Highlights
Rapid Micro Biosystems (NASDAQ:RPID) reported first-quarter 2026 revenue growth and reaffirmed its full-year outlook, citing momentum in system placements, consumables and recurring revenue, while


